{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:12:23Z","timestamp":1783012343550,"version":"3.54.6"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,5]]},"DOI":"10.7759\/cureus.59705","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T05:51:39Z","timestamp":1714974699000},"source":"Crossref","is-referenced-by-count":4,"title":["Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Esraa M","family":"Aledani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Kasapoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Yadavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Althwanay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuheen Sankar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22684","article-title":"Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study","volume":"49","author":"Esmat SM","year":"2017","unstructured":"Esmat SM, Hegazy RA, Gawdat HI, Abdel Hay RM, Allam RS, El Naggar R, Moneib H. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study. Lasers Surg Med. 2017, 49:835-43. 10.1002\/lsm.22684","journal-title":"Lasers Surg Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_89_18","article-title":"Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial","volume":"11","author":"Gajjar PC","year":"2019","unstructured":"Gajjar PC, Mehta HH, Barvaliya M, Sonagra B. Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial. Int J Trichology. 2019, 11:58-67. 10.4103\/ijt.ijt_89_18","journal-title":"Int J Trichology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky AW","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, et al.. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004, 50:541-53. 10.1016\/j.jaad.2003.06.014","journal-title":"J Am Acad Dermatol"},{"key":"ref4","article-title":"Comparing the efficacy of mesotherapy to topical minoxidil in the treatment of female pattern hair loss using ultrasound biomicroscopy: a randomized controlled trial","volume":"27","author":"Hunter N","year":"2019","unstructured":"Hunter N, Sayed K, Hay RA, Allam R, Hussein N. Comparing the efficacy of mesotherapy to topical minoxidil in the treatment of female pattern hair loss using ultrasound biomicroscopy: a randomized controlled trial. Acta Dermatovenerol Croat. 2019, 27:1-7.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003866","article-title":"Intradermal delivery of alopecia therapeutics: current state and future prospects","volume":"49","author":"Alhanshali L","year":"2023","unstructured":"Alhanshali L, Buontempo M, Majerson D, Shapiro J, Lo Sicco K. Intradermal delivery of alopecia therapeutics: current state and future prospects. Dermatol Surg. 2023, 49:851-4. 10.1097\/DSS.0000000000003866","journal-title":"Dermatol Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref9","article-title":"Assessing risk of bias in a randomized trial","volume":"10","author":"Higgins JPT","year":"2023","unstructured":"Higgins JPT, Sterne JAC, Savovic J, et al.. Assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions version 6.4. 2023, 10:29-31.","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000518043","article-title":"Two cases of paradoxical nonscarring alopecia after mesotherapy with dutasteride","volume":"8","author":"Reguero del Cura L","year":"2022","unstructured":"Reguero del Cura L, De Quintana Sancho A, Rubio Lombra\u00f1a M, L\u00f3pez Sundh AE, Gonz\u00e1lez L\u00f3pez MA. Two cases of paradoxical nonscarring alopecia after mesotherapy with dutasteride. Skin Appendage Disord. 2022, 8:46-8. 10.1159\/000518043","journal-title":"Skin Appendage Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14900","article-title":"Current application of mesotherapy in pattern hair loss: a\u00a0systematic review","volume":"21","author":"Tang Z","year":"2022","unstructured":"Tang Z, Hu Y, Wang J, Fan Z, Qu Q, Miao Y. Current application of mesotherapy in pattern hair loss: a\u00a0systematic review. J Cosmet Dermatol. 2022, 21:4184-93. 10.1111\/jocd.14900","journal-title":"J Cosmet Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2245084","article-title":"Systematic review of mesotherapy: a novel avenue for the treatment of hair loss","volume":"34","author":"Gupta AK","year":"2023","unstructured":"Gupta AK, Polla Ravi S, Wang T, Talukder M, Starace M, Piraccini BM. Systematic review of mesotherapy: a novel avenue for the treatment of hair loss. J Dermatolog Treat. 2023, 34:2245084. 10.1080\/09546634.2023.2245084","journal-title":"J Dermatolog Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15247","article-title":"Frontal edema due to mesotherapy for androgenetic alopecia: a case series","volume":"35","author":"Melo DF","year":"2022","unstructured":"Melo DF, Saceda-Corralo D, Tosti A, et al.. Frontal edema due to mesotherapy for androgenetic alopecia: a case series. Dermatol Ther. 2022, 35:e15247. 10.1111\/dth.15247","journal-title":"Dermatol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13585","article-title":"Angioedema-like contact dermatitis caused by mesotherapy with dutasteride","volume":"83","author":"Magdaleno-Tapial J","year":"2020","unstructured":"Magdaleno-Tapial J, Valenzuela-O\u00f1ate C, Garc\u00eda-Legaz-Mart\u00ednez M, et al.. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride. Contact Dermatitis. 2020, 83:246-7. 10.1111\/cod.13585","journal-title":"Contact Dermatitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14622","article-title":"Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo-controlled trial","volume":"34","author":"Uzel BP","year":"2021","unstructured":"Uzel BP, Takano GH, Chartuni JC, Cesetti MV, Gavioli CF, Lemes AM, Costa IM. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo-controlled trial. Dermatol Ther. 2021, 34:e14622. 10.1111\/dth.14622","journal-title":"Dermatol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/216841-mesotherapy-as-a-promising-alternative-to-minoxidil-for-androgenetic-alopecia-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T05:51:43Z","timestamp":1714974703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/216841-mesotherapy-as-a-promising-alternative-to-minoxidil-for-androgenetic-alopecia-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.59705","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,5]]}}}